Company Selected - Astellas Pharma Inc. - Income Statement
| Fiscal Year is From April To March - All Figures are in , Thousands, Except for the Diluted EPS Figure | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | View Chart |
|---|---|---|---|---|---|
| 1,944,993,000 | 1,912,323,000 | 1,867,631,000 | 1,772,155,000 | ||
| 419,699,000 | 416,006,000 | 412,463,000 | 389,837,000 | ||
| 419,699,000 | 416,006,000 | 363,820,000 | 294,210,000 | ||
| 0.0 | 0.0 | 48,643,000 | 95,627,000 | ||
| 1,525,294,000 | 1,496,317,000 | 1,455,168,000 | 1,382,318,000 | ||
| 1,228,273,000 | 1,240,624,000 | 1,224,081,000 | 1,191,040,000 | ||
| - | - | 193,149,000.00 | 392,648,000.00 | ||
| 312,528,000 | 327,651,000 | 329,275,000 | 324,570,000 | ||
| 915,745,000 | 912,973,000 | 701,657,000 | 473,822,000 | ||
| 297,021,000 | 255,693,000 | 231,087,000 | 191,278,000 | ||
| - | - | -62,000.00 | -1,712,000.00 | ||
Hid Interest Expense | 19,080,000 | 17,677,000 | 17,956,000 | 16,559,000 | |
Hid Interest Income | - | - | 4,124,000.00 | 5,304,000.00 | |
| -19,080,000 | -17,677,000 | -13,770,000 | -9,543,000 | ||
| -226,225,000 | -224,797,000 | -309,044,000 | -133,563,000 | ||
| 70,796,000 | 30,875,000 | -77,978,000 | 57,694,000 | ||
| -10,408,000 | -19,510,000 | -20,552,000 | 2,947,000 | ||
| 81,566,000 | 50,747,000 | -57,427,000 | 54,746,000 | ||
Hid [-] Net Income | 81,566,000 | 50,747,000 | -57,427,000 | 54,746,000 | |
| 81,204,000 | 50,385,000 | -57,426,000 | 54,747,000 | ||
HidHidHid Net Income From Continuing Ops | - | - | -33,277,000.00 | -18,764,000.00 | |
HidHidHid Discontinued Operations | - | - | - | - | |
HidHid Minority Interest Expense | -362,000 | -362,000 | 1,000 | 1,000 | |
| 0.0 | 0.0 | 0.0 | 0.0 | ||
| 45.32 | 28.15 | -31.90 | 30.73 | ||
| 1,795,382 | 1,790,203 | 1,789,760 | 1,801,230 | ||
| 483,775,000 | 435,259,000 | 330,347,000 | 271,639,000 | ||
| 287,107,000 | 236,127,000 | 130,255,000 | 75,727,000 |